Tag Archives: psoriatic arthritis

Novartis’ two pivotal Phase III studies of AIN457 (secukinumab) in psoriatic arthritis (PsA) met primary and key secondary endpoints

Posted on 25, September 2014 by

Secukinumab met primary and key secondary endpoints in two pivotal Phase III studies showing superiority to placebo in patients with adult onset psoriatic arthritis (PsA) PsA is a debilitating, long-lasting condition that causes inflammation of joints and skin and affects … Read the full press release →

Posted in Business, Healthcare, Pharma & Biotech, Switzerland, Technology

Tagged , , ,